Supporting our findings, Tang et al. observed that a CpG site located in the regulatory associated protein of MTOR complex 1 (RPTOR) gene, which is an activator of mTOR, was hypomethylated in breast cancer patients compared to healthy controls [33]. Here, MTOR is linked to breast carcinoma.